-
公开(公告)号:DE69617701D1
公开(公告)日:2002-01-17
申请号:DE69617701
申请日:1996-05-28
Applicant: ABBOTT LAB
Inventor: HOLLADAY W , LIN NAN-HORNG , RYTHER B , HE YUN
IPC: A61K31/00 , A61K31/44 , A61K31/4427 , A61K31/4439 , A61P25/00 , A61P25/04 , C07D401/12 , C07D403/12 , C07D417/12
Abstract: Novel 3-pyridyloxymethyl heterocyclic ether compounds having formula (I), wherein * is a chiral center and n, X, R , R , A andB are specifically defined, which are useful in controlling chemical synaptic transmission; therapeutically-effective pharmaceutical compositions therof; and use of said compositions to selectively control synaptic transmission in mammals.
-
公开(公告)号:DK0717741T3
公开(公告)日:2001-08-20
申请号:DK94931741
申请日:1994-08-30
Applicant: ABBOTT LAB
Inventor: LIN NAN-HORNG , HE YUN , ELLIOTT RICHARD L , CHORGHADE MUKUND S , WITTENBERGER STEVEN J , BUNNELLE WILLIAM H , NARAYANAN BIKSHANDAR A , SINGAM PULLA R , ESCH THOMAS K J , BEER DIETER O , WITZIG CHRISTIAN C , HERZIG THOMAS C , RAO ALLA V RAMA
IPC: C07D413/04 , C07D207/09
Abstract: A novel process for preparing enantiomerically-pure 3-methyl-5-(1-(C1-C3-alkyl)-2-pyrrolidinyl)isoxazole in high yield, wherein a protected pyrrolidine or 2-oxo-pyrrolidine starting material is reacted with a suitable organic anion and a resulting beta-keto oxime intermediate is cyclized and dehydrated, as well as intermediates useful in the preparation thereof.
-
23.
公开(公告)号:NZ335810A
公开(公告)日:2001-03-30
申请号:NZ33581097
申请日:1997-12-10
Applicant: ABBOTT LAB
Inventor: HOLLADAY MARK W , ARNERIC STEPHEN P , BAI HAO , DART MICHAEL J , LIN NAN-HORNG , LYNCH JOHN K , OR YAT SUN , RYTHER KEITH B , SULLIVAN JAMES P , WASICAK JAMES T , ERHLICH PAUL P
IPC: A61P25/04 , A61K31/4427 , A61K31/443 , A61K31/4439 , A61K31/485 , A61P25/28 , A61P29/00 , C07D205/04 , C07D401/12 , C07D401/14 , C07D405/14
Abstract: An 3-(2-azetidinyl-methoxy)-pyridine derivative or a pharmaceutically acceptable salt thereof has the compound of formula I wherein: Z, Y, X and the 2-azetidine stereochemistry are, respectively, selected from: a) H, H, Me (R); b) H, H, CN (S); c) H, H, Cl (S); d) H, H, Cl (R); e) H, H, Br (R); f) H, H, F (S); g) H, H, F (R); h) H, H, CHF2 (S); i) H, H, OMe (R); j) H, Me, Cl (S); k) H, Me, Cl (R); l) H, Et, F (S); m) H, ethenyl, Cl (S); n) H, ethenyl, Cl (R); o) H, ethenyl, F (S); p) H, ethenyl, F (R); q) H, ethynyl, Cl (S); r) H, ethynyl, Cl (R); s) H, Cl, Cl (S); t) H, Cl, Cl (R); u) H, Cl, F (S); v) H, Br, Me (S); w) H, Br, Me (R); x) H, Br, Cl (S); y) H, Br, Cl (R); z) H, Br, F (S); aa) H, Br, F (R); bb) H, n-Pr, H (S); cc) H, ethenyl, H (S); dd) H, ethenyl, H (R); ee) H, Cl, H (R); ff) H, F, H (S); gg) H, NO2, H (S); hh) H, OEt, H (S); ii) Cl, H, H (S); jj) Cl, H, H (R); kk) F, H, H (S); ll) F, H, F (S); mm) F, H, Me (S) or nn) F, H, Me (R) and R is H or a prodrug such as methyl, ethyl, isopropyl, n-propyl, isobutyl, t-butyl, t-pentyl, n-pentyl, n-butyl, cyclohexylmethyl, 3-methyl-1-butyn-3 -yl, optionally N-protected-Ala, optionally N-protected-Phe, phthaloyl methyl ester, 4-diethylaminobenzoyl, 2-hydroxymethylbenzoyl, acetyl, t-butyloxycarbonyl, ethoxycarbonyl, phenoxycarbonyl, 4-nitrophenoxycarbonyl, 4-methoxyphenoxycarbonyl, 4-carbomethoxyphenoxycarbonyl, 4-methylphenoxycarbonyl, 4-fluorophenoxycarbonyl, 4-chlorophenoxycarbonyl, 2,6-dimethylphenoxycarbonyl, 1 -acetoxy-1-methyl-ethoxycarbonyl, benzyloxycarbonyl, pyrrolidin-1-ylcarbonyl, N-succinimidylmethyl or N-phthalimidylmethyl or a group of formula 1, 2 (where R' is H or Me), 3, 4 or 5 (where two azetidines are attached). A pharmaceutical composition thereof is useful in controlling pain in mammals. An intermediate compound of formula II is disclosed wherein: L is an anionic leaving group which may be displaced by a nucleophile and P is a nitrogen protecting group.
-
24.
公开(公告)号:CA2381252A1
公开(公告)日:2001-03-22
申请号:CA2381252
申请日:2000-09-14
Applicant: ABBOTT LAB
Inventor: DRIZIN IRENE , LI YIHONG , KINCAID JOHN F , BASHA ANWER , HAKEEM AHMED A , LIN NAN-HORNG , DONG LIMING
IPC: A61K31/4439 , A61K31/444 , A61K31/506 , A61K31/55 , A61P1/00 , A61P1/04 , A61P1/14 , A61P15/10 , A61P21/00 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P25/34 , C07D401/12 , C07D401/14 , C07D409/14 , A61K31/4427
Abstract: A series of 3-pyrrolidinyloxy-3'-pyridyl ether compounds, a method for selectively controlling neurotransmitter release in mammals using these compounds, and pharmaceutical compositions including these compounds. Preferred compounds are 3-pyrrolidinylmethoxy-3'-(5'-and/or 6'-substituted) pyridyl ethers.
-
公开(公告)号:BR9714677A
公开(公告)日:2000-10-03
申请号:BR9714677
申请日:1997-12-10
Applicant: ABBOTT LAB
Inventor: HOLLADAY MARK W , ARNERIC STEPHEN P , BAI HAO , DART MICHAEL J , LIN NAN-HORNG , LYNCH JOHN K , OR YAT SUN , RYTHER KEITH B , SULLIVAN JAMES P , WASICAK JAMES T , EHRLICH PAUL P
IPC: A61P25/04 , A61K31/4427 , A61K31/443 , A61K31/4439 , A61K31/485 , A61P25/28 , A61P29/00 , C07D205/04 , C07D401/12 , C07D401/14 , C07D405/14 , A61K31/44
Abstract: The present invention relates to a method of controlling pain in mammals, including humans, comprising administering to a mammal or patient in need of treatment thereof selected compounds of formula (I) or a pharmaceutically acceptable salt thereof. The invention further relates to selected (R) and (S) compounds of formula (I) which are useful as analgesics as well as neuronal cell death preventors and anti-inflammatories.
-
公开(公告)号:SK75999A3
公开(公告)日:2000-05-16
申请号:SK75999
申请日:1997-12-10
Applicant: ABBOTT LAB
Inventor: HOLLADAY MARK W , ARNERIC STEPHEN P , BAI HAO , DART MICHAEL J , LIN NAN-HORNG , LYNCH JOHN K , OR YAT SUN , RYTHER KEITH B , SULLIVAN JAMES P , WASICAK JAMES T , EHRLICH PAUL P
IPC: A61P25/04 , A61K31/4427 , A61K31/443 , A61K31/4439 , A61K31/485 , A61P25/28 , A61P29/00 , C07D205/04 , C07D401/12 , C07D401/14 , C07D405/14 , A61K31/44
Abstract: The present invention relates to a method of controlling pain in mammals, including humans, comprising administering to a mammal or patient in need of treatment thereof selected compounds of formula (I) or a pharmaceutically acceptable salt thereof. The invention further relates to selected (R) and (S) compounds of formula (I) which are useful as analgesics as well as neuronal cell death preventors and anti-inflammatories.
-
公开(公告)号:TR199901904T2
公开(公告)日:1999-10-21
申请号:TR9901904
申请日:1997-12-10
Applicant: ABBOTT LAB
Inventor: HOLLADAY MARK W , ARNERIC STEPHEN P , BAI HAO , DART MICHAEL J , LIN NAN-HORNG , LYNCH JOHN K , OR YAT SUN , RYTHER KEITH B , SULLIVAN JAMES P , WASICAK JAMES T , EHRLICH PAUL P
IPC: A61P25/04 , A61K31/4427 , A61K31/443 , A61K31/4439 , A61K31/485 , A61P25/28 , A61P29/00 , C07D205/04 , C07D401/12 , C07D401/14 , C07D405/14 , A61K31/44
Abstract: The present invention relates to a method of controlling pain in mammals, including humans, comprising administering to a mammal or patient in need of treatment thereof selected compounds of formula (I) or a pharmaceutically acceptable salt thereof. The invention further relates to selected (R) and (S) compounds of formula (I) which are useful as analgesics as well as neuronal cell death preventors and anti-inflammatories.
-
公开(公告)号:NO992705L
公开(公告)日:1999-08-03
申请号:NO992705
申请日:1999-06-03
Applicant: ABBOTT LAB
Inventor: HOLLADAY MARK W , ARNERIC STEPHEN P , BAI HAO , DART MICHAEL J , LIN NAN-HORNG , LYNCH JOHN K , OR YAT SUN , RYTHER KEITH B , SULLIVAN JAMES P , WASICAK JAMES T , EHRLICH PAUL P
IPC: A61P25/04 , A61K31/4427 , A61K31/443 , A61K31/4439 , A61K31/485 , A61P25/28 , A61P29/00 , C07D205/04 , C07D401/12 , C07D401/14 , C07D405/14 , A61K31/44
Abstract: The present invention relates to a method of controlling pain in mammals, including humans, comprising administering to a mammal or patient in need of treatment thereof selected compounds of formula (I) or a pharmaceutically acceptable salt thereof. The invention further relates to selected (R) and (S) compounds of formula (I) which are useful as analgesics as well as neuronal cell death preventors and anti-inflammatories.
-
29.
公开(公告)号:CA2315117A1
公开(公告)日:1999-07-01
申请号:CA2315117
申请日:1998-12-18
Applicant: ABBOTT LAB
Inventor: HE YUN , LEBOLD SUZANNE A , ELLIOTT RICHARD L , BAI HAO , DART MICHAEL J , WASICAK JAMES T , KINCAID JOHN F , GARVEY DAVID S , LI YIHONG , RYTHER KEITH , HOLLADAY MARK W , EHRLICH PAUL P , ABREO MELWYN A , GUNN DAVID E , LIN NAN-HORNG , SCHKERYANTZ JEFFREY M , LYNCH JOHN K
IPC: A61K31/427 , A61K31/4427 , A61K31/4439 , A61K31/4545 , A61K31/4709 , A61K31/4725 , A61K31/497 , A61K31/501 , A61K31/506 , A61P25/00 , A61P25/22 , A61P25/28 , A61P25/30 , A61P43/00 , C07D401/12 , C07D403/12 , C07D417/12 , C07D455/02 , C07D487/04 , A61K31/40 , A61K31/425 , A61K31/44 , A61K31/47 , A61K31/50 , A61K31/505
Abstract: Novel compounds having formulas (I), (II) or (III) or pharmaceuticallyacceptable salts or prodrugs thereof, which are useful for controlling synaptic transmission; to therapeutically-effective pharmaceutical compositions of these compounds; and to the use of said compositions to controlling synaptic transmission in human or veterinary patients.
-
公开(公告)号:CA2281800A1
公开(公告)日:1998-08-27
申请号:CA2281800
申请日:1998-02-05
Applicant: ABBOTT LAB
Inventor: RYTHER KEITH B , WASICAK JAMES T , HOLLADAY MARK W , LIN NAN-HORNG , GARVEY DAVID S
IPC: A61P25/04 , A61K31/422 , A61K31/4439 , A61K31/4725 , A61P25/00 , A61P43/00 , C07D487/04 , A61K31/44
Abstract: 7a-Substituted hexahydro-1H-pyrrolizine compounds having formula (I), wherein A is a defined heterocycle moiety, pharmaceutical compositions of these compounds, and use of said compositions to selectively control synaptic transmission in mammals.
-
-
-
-
-
-
-
-
-